Biotechnology
Novavax’s Strategic Leap in Vaccine Development
Novavax's Financial Outlook and Expedites COVID-19 and Influenza Vaccine Initiatives Novavax (NVAX), a leading vaccine developer, has announced a groundbreaking...
Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales
Biotech Company Reiterates Sales Guidance, Anticipates Launch of RSV Vaccine Moderna (MRNA), the biotech company at the forefront of Covid...
Candel Therapeutics’ CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer
Milestone Achievement Enhances Development Efforts for Multimodal Biological Immunotherapy Candel Therapeutics (CADL) has achieved a significant milestone in its fight...
Rallybio Collaborates with Johnson & Johnson to Tackle Rare Disease FNAIT
Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia Rallybio Corporation (RLYB) has announced a collaboration with...
Moderna’s Cancer Vaccine Shows Positive Results, Shares Surge
Early-Stage Trial Signals Potential Breakthrough in Cancer Treatment Moderna (MRNA) witnessed a significant uptick in its shares, climbing 8% to...
Acrivon Therapeutics Secures $130 Million in Private Financing for Precision Oncology Advancements
Biopharmaceutical Company Raises Capital to Propel Clinical Trials and Innovative Research Acrivon Therapeutics (ACRV), a pioneer in precision oncology medicines,...
Allurion Launches Virtual Care Suite for Obesity Management
Comprehensive Digital Solution Aims to Enhance Patient Outcomes and Clinic Efficiency Allurion Technologies, Inc. has unveiled its Virtual Care Suite...
TC BioPharma Announces Strategic Expansion with NK Cell Therapeutics
Acquisition of CAR-NK Assets to Bolster Cancer Therapy Portfolio TC BioPharm (TCBP), a leading biotechnology company specializing in allogeneic gamma-delta...
Candel Therapeutics Reports Encouraging Survival Data for CAN-2409 in Pancreatic Cancer
Updated Interim Results Show Prolonged Survival and Immune Activation in Borderline Resectable PDAC Patients Candel Therapeutics (CADL), a clinical-stage biopharmaceutical...
ARCA Biopharma and Oruka Therapeutics Announce Merger to Pave the Way for Advanced Biologic Treatments
Combined Entity Aims to Revolutionize Chronic Skin Disease Treatment with Cutting-Edge Antibodies ARCA biopharma (ABIO) and Oruka Therapeutics have finalized...
